You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨國盛證券:藥明康德在手訂單超預期,維持“買入”評級
格隆匯 03-24 15:47

國盛證券研報指出,藥明康德(603259.SH)24年實現經調整Non-IFRS歸母淨利潤爲105.8億元,經調歸母淨利率爲27.0%,創歷史新高。客戶基礎穩固,在手訂單超預期。指引方面,預計2025年持續經營業務收入將顯著增長,達到415-430億元,公司推進全球D&M產能建設,預計2025年資本開支70-80億元,自由現金流達到40-50億元,顯示出強勁的增長潛力和盈利能力。在股東分紅方面,公司在維持30%年度現金分紅比例的基礎上,擬額外一次性派發10億特殊分紅,並在2025年增加中期分紅,同時擬在2025年適時回購10億元A股。維持“買入”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account